Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Urinary Bladder Neoplasms 26Non-Muscle Invasive Bladder Neoplasms 13Colorectal Neoplasms 3Colonic Neoplasms 3Recurrence 2Neoplasms 2Melanoma 2Lung Neoplasms 2Side Effect of Drug 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Osteosarcoma 1Oligospermia 1Neuroblastoma 1Fibrosis 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma in Situ 1Breast Neoplasms 1

Interventions

Doxorubicin 142Ifosfamide 85Radiotherapy 82Cyclophosphamide 72Gemcitabine 63Filgrastim 54pembrolizumab 43pazopanib 40Etoposide 39Docetaxel 39Vincristine 37Trabectedin 37Cisplatin 35Nivolumab 32Magnetic Resonance Spectroscopy 26Irinotecan 26Carboplatin 25Temozolomide 23Surgical Procedures, Operative 23Radiation 22Ipilimumab 22Bevacizumab 20Blood Specimen Collection 19Granulocyte Colony-Stimulating Factor 18Biopsy 18eribulin 17Sirolimus 17Mesna 17Melphalan 17Dactinomycin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × BCG Vaccine × Clear all
NCT00003023 2013-01-18

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
24 enrolled
CNSSarcoma

Neuroblastoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡